Indocyanine Green for Solid Tumors
NCT02280954
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Neoplasms
Interventions
DRUG:
Indocyanine Green (ICG)
Sponsor
University of Pennsylvania